{"id":271,"date":"2012-10-24T12:30:00","date_gmt":"2012-10-24T12:30:00","guid":{"rendered":"https:\/\/nolato.wpengine.com\/?mfn_news=strong-sales-and-profit-trend"},"modified":"2012-10-24T12:30:00","modified_gmt":"2012-10-24T12:30:00","slug":"strong-sales-and-profit-trend","status":"publish","type":"mfn_news","link":"https:\/\/temporary.nolato.com\/de\/mfn_news\/strong-sales-and-profit-trend\/","title":{"rendered":"Strong sales and profit trend"},"content":{"rendered":"<div class=\"mfn-preamble\"><strong><\/strong><\/div>\n<p><span>In today\u2019s interim report for the third quarter of 2012, Nolato reports a strong performance for both sales and profit. Group sales increased 39% to SEK 999 million (718). Operating profit (EBITA) rose to SEK 84 million (54) and earnings per share rose to SEK 1.98 (1.37). <\/span><\/p>\n<p><span>\u201cIt is highly pleasing that our strong performance continued in the third quarter,\u201d says President and CEO of Nolato, Hans Porat. <\/span><\/p>\n<p><span>Business area Nolato Medical\u2019s sales rose 31% to SEK 288 million (220). Operating profit (EBITA) increased to SEK 32 million (25), with an EBITA margin of 11.1% (11.4). The newly acquired company in the UK, Nolato Jaycare, was consolidated on 1 April and accounted for SEK 67 million of the business area\u2019s sales in the quarter. <\/span><\/p>\n<p><span>\u201cNolato Medical\u2019s product sales were in line with the market, while the project-related sales remained low,\u201d says Hans Porat. \u201cThe British unit acquired in the spring is performing according to plan.\u201d <\/span><\/p>\n<p><span>Business area Nolato Telecom\u2019s sales doubled to SEK 444 million (220). Operating profit (EBITA) increased to SEK 35 million (7), with an EBITA margin of 7.9% (2.3 ex. non-recurring items). <\/span><\/p>\n<p><span>\u201cDemand for the new product portfolio has remained very strong,\u201d says Hans Porat. \u201cInventory build-up has also occurred among customers ahead of the Chinese public holidays at the beginning of the fourth quarter.\u201d <\/span><\/p>\n<p><span>Business area Nolato Industrial\u2019s sales amounted to SEK 268 million (279). Operating profit (EBITA) totalled SEK 24 million (26), with an EBITA margin of 9.0% (9.3). <\/span><\/p>\n<p><span>\u201cAt the end of the quarter we noted a cyclical slowdown for many of the segments in the business area,\u201d continues Hans Porat. <\/span><\/p>\n<p><span>Nolato\u2019s financial position remains strong. At the end of the quarter, net debt stood at SEK 286 million (66), with an equity\/assets ratio of 45% (52). The net debt has risen as a consequence of financing the acquisition and an increased working capital requirement. <\/span><\/p>\n<p><span>The year-end report for 2012 will be released on 5 February 2013. The Annual General Meeting will be held on 25 April 2013.<\/span><\/p>\n<div class=\"mfn-footer\">\n<p><span><em>&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8211;<br \/><\/em><em>For further information, please contact:\u00a0<br \/><\/em><em>Hans Porat, President and CEO, telephone 46 431 442294\u00a0<\/em><\/span><br \/><span><em>Per-Ola Holmstr\u00f6m, Executive Vice President and CFO, telephone 46 431 442293<\/em><\/span><\/p>\n<\/div>\n","protected":false},"excerpt":{"rendered":"<p>In today\u2019s interim report for the third quarter of 2012, Nolato reports a strong performance for both sales and profit. Group sales increased 39% to SEK 999 million (718). Operating profit (EBITA) rose to SEK 84 million (54) and earnings per share rose to SEK 1.98 (1.37). \u201cIt is highly pleasing that our strong performance&hellip; <a class=\"more-link\" href=\"https:\/\/temporary.nolato.com\/de\/mfn_news\/strong-sales-and-profit-trend\/\">Continue reading <span class=\"screen-reader-text\">Strong sales and profit trend<\/span><\/a><\/p>\n","protected":false},"template":"","class_list":["post-271","mfn_news","type-mfn_news","status-publish","hentry","mfn-news-tag-mfn-lang-en","mfn-news-tag-mfn-report-interim","mfn-news-tag-mfn-type-ir","mfn-news-tag-mfn-regulatory-mar","mfn-news-tag-mfn","mfn-news-tag-mfn-report-interim-q3","mfn-news-tag-mfn-regulatory","mfn-news-tag-mfn-report","entry"],"translation":{"provider":"WPGlobus","version":"3.0.0","language":"de","enabled_languages":["en","es","de","fr","ru","sv"],"languages":{"en":{"title":true,"content":true,"excerpt":false},"es":{"title":false,"content":false,"excerpt":false},"de":{"title":false,"content":false,"excerpt":false},"fr":{"title":false,"content":false,"excerpt":false},"ru":{"title":false,"content":false,"excerpt":false},"sv":{"title":false,"content":false,"excerpt":false}}},"_links":{"self":[{"href":"https:\/\/temporary.nolato.com\/de\/wp-json\/wp\/v2\/mfn_news\/271","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/temporary.nolato.com\/de\/wp-json\/wp\/v2\/mfn_news"}],"about":[{"href":"https:\/\/temporary.nolato.com\/de\/wp-json\/wp\/v2\/types\/mfn_news"}],"wp:attachment":[{"href":"https:\/\/temporary.nolato.com\/de\/wp-json\/wp\/v2\/media?parent=271"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}